Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-11

Clinical Trial Update: Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating dupilumab's effect on pruritus neuro-mechanisms in adults with atopic dermatitis; results completed and posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Dermatitis Atopic | Phase 4 | Status: COMPLETED | Results posted: 2023-07-11